To Skecher USA’s (SKX-$20.50) credit, the shoe manufacturer recognized the willingness of American consumers (mostly women) to purchase footwear products developed to (allegedly) firm-up lower body muscles — and seized first-mover advantage in that niche. However, recent quarterly results suggest that the days of explosive sales and easy profits for its Shape-up product line are over.
Continue Reading at CBS Interactive
Editor David J Phillips does not hold a financial interest in any stocks mentioned in this article. The 10Q Detective has a Full Disclosure Policy.
Continue Reading at CBS Interactive
Editor David J Phillips does not hold a financial interest in any stocks mentioned in this article. The 10Q Detective has a Full Disclosure Policy.
